P1132 PHARMACOKINETIC-RESPONSE ANALYSIS OF FALDAPREVIR IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION WITH PRIOR RELAPSE von Asselah, T, Zehnter, E, Agarwal, K, Sakai, Y, Yatsuhashi, H, Willems, B, Wright, D, Calinas, F, Calleja, J.L, Negro, F, Stern, J.O, Quinson, A.-M, Sha, N, Dorleacq, N, Schobelock, M, Jacobson, I.M

Volltext

Antiviral activity of low‐dose alovudine in antiretroviral‐experienced patients: results from a 4‐week randomized, double‐blind, placebo‐controlled dose‐ranging trial von Ghosn, J, Quinson, A‐M, Sabo, ND, Cotte, L, Piketty, C, Dorléacq, N, Bravo, M‐L, Mayers, D, Harmenberg, J, Mårdh, G, Valdez, H, Katlama, C

Volltext